Zepp Health Reports Lower Revenue but Higher Margins
Company Announcements

Zepp Health Reports Lower Revenue but Higher Margins

Zepp Health (ZEPP) has released an update.

Zepp Health Corporation faced a 56% revenue decline in the second quarter of 2024 compared to the previous year, reporting $40.6 million in revenue and a significant drop in units shipped. Despite this, the company achieved a record-high gross margin of 40.3%, driven by a strategic focus on self-branded products and a reduction in clearance sales. The firm anticipates continued gross margin improvement and is preparing to launch new AI-integrated products in the wearable tech market.

For further insights into ZEPP stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskZepp Health Back in NYSE Good Graces
TheFlyZepp Health regains compliance with NYSE minimum price
TheFlyZepp Health falls -11.0%
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App